ð¬èèªæµ®è «ïŒãªãããŒãïŒãšã¯ïŒäžè¢ã®èšºæåºæºã«æ°ããªå
èèªæµ®è «ïŒãªãããŒãïŒã¯ãäž»ã«å¥³æ§ã«çºçããæ ¢æ§çãªé²è¡æ§ã®ç æ°ã§ãæè¶³ã«äžåè¡¡ãã€å¯Ÿç§°çã«èèªçµç¹ãèç©ããããšãç¹åŸŽã§ããç¹ã«ãäžè¢ïŒè ïŒã«èèªãèç©ããã¿ã€ãïŒã¿ã€ãIVïŒã¯ãèèªæµ®è «æ£è ããã®çŽ30%ã«èŠãããŸãããã®ç æ°ã¯èŠãç®ã®åé¡ã ãã§ãªããçã¿ãéã ãããããã¿ãªã©ã®çç¶ãåŒãèµ·ãããæ£è ããã®ç掻ã®è³ªã倧ããäœäžãããããšããããŸãããããããã®èšºæã¯é£ããããã°ãã°ä»ã®ç æ°ãšééããããã蚺æãé ãããããããšãå°ãªããããŸããããã®ãããªèæ¯ãããäžè¢ã®èèªæµ®è «ããã客芳çãã€æ£ç¢ºã«èšºæããããã®æ¹æ³ãæ±ããããŠããŸãããæ¬ç ç©¶ã¯ãè¶ é³æ³¢æ€æ»ãçšããŠäžè¢ã®èèªæµ®è «ã®èšºæåºæºã確ç«ããããšãç®æããŸããã
ð§ªç ç©¶ã®æŠèŠã𿹿³
ç ç©¶ã®ç®ç
æ¬ç ç©¶ã®äž»ãªç®çã¯ãäžè¢ã®èèªæµ®è «ãæã€å¥³æ§ãšã幎霢ããã³BMIïŒäœæ Œææ°ïŒâ»1ãäžèŽããå¥åº·ãªå¥³æ§ã®ç®äžçµç¹ã®åããè¶ é³æ³¢ã§æž¬å®ãã䞡矀éã§æ¯èŒããããšã§ãããããã«ãäžè¢ã®èèªæµ®è «ã蚺æããããã®å®¢èгçãªã«ãããªãå€â»2ãèšå®ããããšãç®æããŸããã
ç ç©¶ãã¶ã€ã³ãšåå è
ãã®ç ç©¶ã¯ã暪æççäŸå¯Ÿç §ç ç©¶â»3ãšããŠå®æœãããŸãããåèš102åã®å¥³æ§ãç ç©¶ã«åå ããŸãããå èš³ã¯ãèšåºçã«èèªæµ®è «ãšèšºæããã女æ§51åãšã幎霢ãšBMIãäžèŽããå¥åº·ãªå¯Ÿç §çŸ€ã®å¥³æ§51åã§ãã
æž¬å®æ¹æ³
åå è ã®äž¡åŽäžè¢ã«ãããŠã6ã€ã®æšæºåãããè§£ååŠçãã€ã³ãâ»4ã§è¶ 鳿³¢æž¬å®ãè¡ãããŸãããæž¬å®ãããã®ã¯ãç®èã®è¡šé¢ã«ããçç®è¡šç®æ¥åéšâ»5ãããçèãèŠãæ·±éšçèâ»6ãŸã§ã®ç®äžçµç¹ã®åãã§ãããã®æ¹æ³ã«ãããèèªçµç¹ã®åããæ£ç¢ºã«è©äŸ¡ããããšãå¯èœãšãªããŸãã
ããŒã¿è§£æ
åŸãããããŒã¿ã¯ãROCæ²ç·ïŒReceiver Operating Characteristic curveïŒâ»7ãçšããŠè§£æãããŸãããããã«ãããåæž¬å®éšäœã«ããã蚺æã®æ§èœãè©äŸ¡ãããèèªæµ®è «ã蚺æããããã®æé©ãªã«ãããªãå€ãå°ãåºãããŸããã
â»1 BMIïŒBody Mass IndexïŒ: äœæ Œææ°ãäœéãšèº«é·ããèšç®ãããè¥æºåºŠãè¡šãææšã§ãã
â»2 ã«ãããªãå€: 蚺æã®å¢çãšãªãæ°å€ã§ãããã®å€ãè¶
ãããšç
æ°ã§ããå¯èœæ§ãé«ããšå€æãããŸãã
â»3 暪æççäŸå¯Ÿç
§ç ç©¶: ããæç¹ã§ã®ç
æ°ãæã€äººïŒçäŸïŒãšæããªã人ïŒå¯Ÿç
§ïŒãæ¯èŒããç
æ°ãšé¢é£ããèŠå ã調ã¹ãç ç©¶ãã¶ã€ã³ã§ãã
â»4 æšæºåãããè§£ååŠçãã€ã³ã: èª°ãæž¬å®ããŠãåãå Žæãæãããã«ãäœã®ç¹å®ã®ç®å°ã«åºã¥ããŠå®ããããæž¬å®ç¹ã§ãã
â»5 çç®è¡šç®æ¥åéš: ç®èã®è¡šé¢ã«ãã衚ç®ãšããã®äžã«ããçç®ã®å¢ç®ã®éšåã§ãã
â»6 æ·±éšçè: çèãèŠã£ãŠããçµåçµç¹ã®èã§ãç®èã®æ·±ãéšåã«ãããŸãã
â»7 ROCæ²ç·ïŒReceiver Operating Characteristic curveïŒ: 蚺æãã¹ãã®æ§èœãè©äŸ¡ããããã®ã°ã©ãã§ãããã®æ²ç·ãçšããããšã§ã蚺æã®æåºŠãšç¹ç°åºŠã®ãã©ã³ã¹ãè©äŸ¡ã§ããŸãã
ðäž»ãªç ç©¶çµæ
æ¬ç ç©¶ã®çµæãèèªæµ®è «çŸ€ã§ã¯ãå¯Ÿç §çŸ€ãšæ¯èŒããŠããã¹ãŠã®æž¬å®éšäœã§ç®äžçµç¹ã®åããææã«å€§ããããšãæããã«ãªããŸããããã®å·®ã¯ãåå è ã®BMIã«é¢ãããèªããããŸããã
äžè¢ã®èèªæµ®è «èšºæã«ãããè¶ é³æ³¢æž¬å®ã®æ§èœ
ç¹ã«ãäžè äžå€®éšïŒè 窩ç·ãã10cmé äœâ»8ïŒããèèªæµ®è «ã®èšºæã«ãããŠæãåªããæ§èœã瀺ããŸããããã®éšäœã§ã¯ãAUCïŒArea Under the CurveïŒâ»9ã0.74ãšé«ããæåºŠâ»10ã82.4%ãç¹ç°åºŠâ»11ã51.9%ã§ããããã®éšäœã®ã«ãããªãå€ã¯11.4mmè¶ ãšèšå®ãããŸããããŸãã6ã€ã®æž¬å®ç¹ã®ãã¡4ã€ã®éšäœã§ãè¯å¥œãªèšºæç²ŸåºŠïŒAUC 0.73ïœ0.74ïŒã瀺ãããŸããã
以äžã«ãäž»èŠãªæž¬å®éšäœã«ãããèšºææ§èœã®æŠèŠã瀺ããŸãã
| 枬å®éšäœ | AUC | æåºŠ | ç¹ç°åºŠ | ã«ãããªãå€ |
|---|---|---|---|---|
| äžè äžå€®éšïŒè 窩ç·ãã10cmé äœïŒ | 0.74 | 82.4% | 51.9% | >11.4 mm |
| ä»ã®3ã€ã®è¯å¥œãªç²ŸåºŠã瀺ããéšäœ | 0.73-0.74 | ïŒè©³çްç¥ïŒ | ïŒè©³çްç¥ïŒ | ïŒè©³çްç¥ïŒ |
â»8 é äœ: äœã®äžå¿ããé ãæ¹ãæãå»åŠçšèªã§ãã
â»9 AUCïŒArea Under the CurveïŒ: ROCæ²ç·ã®äžã®é¢ç©ã§ã蚺æãã¹ãã®å
šäœçãªç²ŸåºŠãç€ºãææšã§ãã1ã«è¿ãã»ã©ç²ŸåºŠãé«ãããšãæå³ããŸãã
â»10 æåºŠ: ç
æ°ã®äººãæ£ãããç
æ°ã§ããããšå€æã§ããå²åã§ãã
â»11 ç¹ç°åºŠ: ç
æ°ã§ãªãäººãæ£ãããç
æ°ã§ãªãããšå€æã§ããå²åã§ãã
ð€ç ç©¶çµæã®èå¯
ä»åã®ç ç©¶çµæã¯ãè¶ é³æ³¢æ€æ»ãäžè¢ã®èèªæµ®è «ã®èšºæã«ãããŠãéåžžã«æçšãªããŒã«ãšãªãåŸãããšã瀺åããŠããŸããç¹ã«ãæšæºåãããè§£ååŠçãã€ã³ãã§ã®ç®äžçµç¹ã®åãæž¬å®ãšãããã«åºã¥ããŠèšå®ãããã«ãããªãå€ã¯ãèšåºçŸå Žã§ã®å®¢èгçãªèšºæè£å©ãšããŠå€§ããªæåŸ ãå¯ããããŸãã
èèªæµ®è «ã®èšºæã¯ããããŸã§äž»ã«èšåºçãªæèŠïŒèŠèšºã觊蚺ïŒã«äŸåããŠããŸãããããããã®æèŠã¯äž»èгçã«ãªããã¡ã§ã蚺æå»ã®çµéšãæéã«ãã£ãŠã°ãã€ããçããããšããããŸãããè¶ é³æ³¢æ€æ»ã¯ãé䟵襲çïŒäœãå·ã€ããªãïŒã§ãæ¯èŒçå®äŸ¡ããããŠãªã¢ã«ã¿ã€ã ã§ç»åã確èªã§ãããšããå©ç¹ããããŸããããã«ãæ¬ç ç©¶ã§ç€ºãããããã«ãBMIã«å·Šå³ãããã«èèªçµç¹ã®åãã®å·®ãæ€åºã§ããããšã¯ãè¥æºã䌎ãèèªæµ®è «æ£è ããã®èšºæã«ãããŠãç¹ã«éèŠã§ãã
äžè äžå€®éšãæãé«ãèšºææ§èœã瀺ããããšã¯ããã®éšäœãäžè¢ã®èèªæµ®è «ã®ç¹åŸŽçãªèèªèç©ãã¿ãŒã³ãåæ ããŠããå¯èœæ§ã瀺ããŠããŸãããã®ç¥èŠã¯ãä»åŸãèèªæµ®è «ã®ã¹ã¯ãªãŒãã³ã°ã蚺æããã»ã¹ã®å¹çåã«è²¢ç®ããã§ããããè¶ é³æ³¢æ€æ»ã¯ãã¢ã¯ã»ã¹ãããããåçŸæ§ãé«ããããå°éå»ã ãã§ãªããäžè¬ã®å»çæ©é¢ã§ãå°å ¥ãããã蚺æè£å©ããŒã«ãšãªãå¯èœæ§ããããŸãã
ð¡å®ç掻ãžã®ã¢ããã€ã¹
ããããªããäžè¢ã®èèªæµ®è «ãããããªããšæãããã以äžã®ç¹ã«çæããé©åãªè¡åããšãããšã倧åã§ãã
- å°éå»ãžã®çžè«: è ã®èèªãäžåè¡¡ã«èç©ããŠãããçã¿ãéã ããããããããã¿ãæ°ã«ãªããªã©ã®çç¶ãããå Žåã¯ãèèªæµ®è «ã®å°éå»ããªã³ãæµ®è «ã®å°é倿¥ãå蚺ããŸããããæ©æã®èšºæãšä»å ¥ããçç¶ã®é²è¡ãæããçæŽ»ã®è³ªãç¶æããããã«éèŠã§ãã
- è¶ é³æ³¢æ€æ»ã®æŽ»çš: æ¬ç ç©¶ã§ç€ºãããããã«ãè¶ é³æ³¢æ€æ»ã¯äžè¢ã®èèªæµ®è «ã®èšºæã«åœ¹ç«ã€å®¢èгçãªããŒã«ã§ãã蚺æã«è¿·ããããå Žåãããã客芳çãªè©äŸ¡ãåžæããå Žåã¯ãè¶ é³æ³¢æ€æ»ã®å®æœã«ã€ããŠå»åž«ã«çžè«ããŠã¿ãŸãããã
- èªå·±ç®¡çã®éèŠæ§: èèªæµ®è «ãšèšºæãããå Žåããªã³ããã¬ããŒãžïŒãªã³ãæ¶²ã®æµããä¿ããããµãŒãžïŒãå§è¿«çæ³ïŒåŒŸæ§å 垯ã匟æ§çè¡£ã«ããå§è¿«ïŒãé©åãªéåããã©ã³ã¹ã®åããé£äºãªã©ãæ¥ã ã®èªå·±ç®¡çãéåžžã«éèŠã§ãããããã¯çç¶ã®ç·©åãé²è¡ã®æå¶ã«åœ¹ç«ã¡ãŸãã
- æ å ±åéãšãµããŒã: èèªæµ®è «ã«é¢ããæ£ç¢ºãªæ å ±ãåéããæ£è äŒããµããŒãã°ã«ãŒãã«åå ããããšãæå¹ã§ããåãç æ°ãæã€äººã ãšã®äº€æµã¯ã粟ç¥çãªæ¯ããšãªããç æ°ãšã®åãåãæ¹ãåŠã¶è¯ãæ©äŒãšãªããŸãã
ð§ç ç©¶ã®éçãšä»åŸã®èª²é¡
æ¬ç ç©¶ã¯ãäžè¢ã®èèªæµ®è «èšºæã«ãããè¶ é³æ³¢æ€æ»ã®æçšæ§ã瀺ãéèŠãªäžæ©ã§ãããããã€ãã®éçãååšããŸãã
- çäŸå¯Ÿç §ç ç©¶ã®æ§è³ª: ãã®ç ç©¶ã¯æšªæççäŸå¯Ÿç §ç ç©¶ã§ãããç¹å®ã®æç¹ã§ã®æ¯èŒã«åºã¥ããŠããŸããç æ°ã®é²è¡ã«äŒŽãå€åããæ²»ç广ã®è©äŸ¡ã«ã¯ãããé·æçãªè¿œè·¡ç ç©¶ãå¿ èŠã§ãã
- ãµã³ãã«ãµã€ãº: åå è æ°ã102åãšæ¯èŒçéãããŠãããããããå€§èŠæš¡ãªç ç©¶ã§çµæã®åçŸæ§ã確èªããå¿ èŠããããŸãã
- åäžæœèšç ç©¶ã®å¯èœæ§: æé²ããã¯äžæã§ãããããåäžæœèšã§ã®ç ç©¶ã§ããã°ãä»ã®å»çæ©é¢ãå°åã§ã®çµæã®äžè¬åã«ã¯æ³šæãå¿ èŠã§ãã
- ä»ã®éšäœãžã®é©çš: æ¬ç ç©¶ã¯äžè¢ã«çŠç¹ãåœãŠãŠããŸãããèèªæµ®è «ã¯äžè¢ã«ãå€ãèŠãããŸããäžè¢ãžã®è¶ 鳿³¢èšºæåºæºã®ç¢ºç«ãä»åŸã®èª²é¡ã§ãã
- 蚺æã®ç¹ç°åºŠ: äžè äžå€®éšã®èšºææ§èœã«ãããŠãæåºŠã¯é«ãã£ããã®ã®ãç¹ç°åºŠã¯51.9%ãšæ¯èŒçäœãå€ã§ãããããã¯ãèèªæµ®è «ã§ã¯ãªã人ã®äžéšããèèªæµ®è «ã§ããããšèª€ã£ãŠå€æããå¯èœæ§ãçŽåæ°ããããšãæå³ããŸãã蚺æã®ç²ŸåºŠãããã«é«ããããã®è¿œå çãªææšããä»ã®èšºææ¹æ³ãšã®çµã¿åãããæ€èšãããã¹ãã§ãã
ãããã®éçãèžãŸããä»åŸã¯ããå€§èŠæš¡ãªå€æœèšå ±åç ç©¶ããç°ãªãäººçš®ã»æ°æã§ã®æ€èšŒãé·æçãªè¿œè·¡ç ç©¶ããããŠä»ã®ç»åèšºææ³ïŒMRIãªã©ïŒãšã®æ¯èŒæ€èšãéããŠãè¶ é³è «æ€æ»ã®èšºæèœåãããã«åäžãããããšãæåŸ ãããŸãã
ðãŸãšã
æ¬ç ç©¶ã¯ãè¶ é³æ³¢æ€æ»ãäžè¢ã®èèªæµ®è «ïŒãªãããŒãïŒã®èšºæã«ãããŠã客芳çã§åçŸæ§ã®ããè£å©ããŒã«ãšãªãåŸãããšã瀺ããŸãããç¹ã«ãäžè äžå€®éšã®ç®äžçµç¹ã®åãæž¬å®ã¯ãé«ãæåºŠãšè¯å¥œãªèšºæç²ŸåºŠã瀺ãã蚺æã®ã«ãããªãå€ãèšå®ãããŸããããã®ææã¯ããããŸã§èšºæãé£ããã£ãäžè¢ã®èèªæµ®è «ã®æ©æçºèŠãšé©åãªæ²»çä»å ¥ã«è²¢ç®ããå¯èœæ§ãç§ããŠããŸããè¶ é³æ³¢æ€æ»ã¯ãèšåºçŸå Žã§ã®èèªæµ®è «ã®è©äŸ¡ãè£å®ããæ£è ããã®èšºæããã»ã¹ãããæ£ç¢ºãã€å¹ççã«é²ããããã®éèŠãªææ®µãšãªãã§ãããã
ðé¢é£ãªã³ã¯é
- æ¥æ¬ãªã³ãæµ®è «åŠäŒ
- é£ç æ å ±ã»ã³ã¿ãŒ
- åçåŽåç
- Mayo Clinic – Lipedema (è±èª)
- National Institutes of Health (NIH) (è±èª)
æžèªæ å ±
| DOI | 10.1177/02683555261475099 |
|---|---|
| PMID | 42527880 |
| PubMed URL | https://pubmed.ncbi.nlm.nih.gov/42527880/ |
| çºè¡å¹Ž | 2026 |
| èè å | Barros Fanilda Souto, Tavares Isabela Rodrigues, Frasson Patricia Henriques Lyra, De Nadai Ana Carolina Carvalho |
| èè æå± | Instituto Fanilda Barros, Vascular Ultrasound Unit, Vitória, ES, Brazil.; Prime Care Medical Complex, Vascular Surgery Unit, São Paulo, SP, Brazil.; ClÃnica PatrÃcia Lyra, Plastic Surgery Unit, Vitória, ES, Brazil.; ClÃnica Vasti, Plastic Surgery Unit, São Paulo, SP, Brazil. |
| éèªå | Phlebology |